Redx

Concentra's Buy Offer May Jeopardize Jounce's Merger with Redx
Concentra's Buy Offer May Jeopardize Jounce's Merger with Redx
BioSpace
Jounce Therapeutics
Redx
Concerta
M&A
Flag link:
Jounce Slashes 57% of Staff, Drops Assets in Stock Merger with Redx
Jounce Slashes 57% of Staff, Drops Assets in Stock Merger with Redx
BioSpace
Jounce Therapeutics
Redx
M&A
layoffs
Flag link:
Conditions are ripe for reverse mergers
Conditions are ripe for reverse mergers
EP Vantage
M&A
reverse merger
Redx
Jounce Therapeutics
Pherecydes
Erytech
Flame Biosciences
Leap Therapeutics
Elicio Therapeutics
Angion
Flag link:
Jazz inks Redx pact to secure 2 targeted cancer therapies
Jazz inks Redx pact to secure 2 targeted cancer therapies
Fierce Biotech
Jazz Pharmaceuticals
Redx
cancer
targeted therapies
Flag link:
Redx shares soar after IPF drug license deal with AstraZeneca
Redx shares soar after IPF drug license deal with AstraZeneca
Pharmaforum
Redx
AstraZeneca
IPF
RXC006
Flag link:
Waksal's bid for Redx ends, forcing biotech to avert cash crunch
Waksal's bid for Redx ends, forcing biotech to avert cash crunch
Fierce Biotech
Redx
Sam Waksal
M&A
Flag link:
Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
Yahoo/PR Newswire
Jazz Pharmacueitcals
Redx
pan-Raf kinase inhibitors
Flag link:
Redx gets regulatory nod to restart RXC004 clinical trial
Redx gets regulatory nod to restart RXC004 clinical trial
Pharmaceutical Business Review
Redx
MHRA
RXC004
clinical trials
solid tumors
Flag link: